|1.||Ocular Hypertension (Glaucoma, Suspect)
|2.||Open-Angle Glaucoma (Glaucoma, Open Angle)
|3.||Retinal Vein Occlusion
|1.||Park, Ki Ho: 13 articles (12/2015 - 07/2005)|
|2.||Araie, Makoto: 13 articles (09/2014 - 01/2002)|
|3.||Kim, Dong Myung: 12 articles (01/2015 - 07/2005)|
|4.||Sugiyama, Kazuhisa: 11 articles (09/2015 - 10/2003)|
|5.||Kashiwagi, Kenji: 10 articles (06/2011 - 07/2004)|
|6.||Yamamoto, Tetsuya: 9 articles (09/2014 - 01/2002)|
|7.||Tomita, Goji: 8 articles (01/2014 - 01/2002)|
|8.||Yamamoto, T: 8 articles (08/2013 - 03/2000)|
|9.||Kimura, Itaru: 8 articles (01/2012 - 04/2002)|
|10.||Iijima, Hiroyuki: 8 articles (06/2011 - 01/2006)|
|1.||latanoprost (Xalatan)FDA Link
03/01/2003 - "NTG: Latanoprost is effective in normal tension glaucoma (NTG), lowering IOP, improving pulsatile ocular blood flow and increasing ocular perfusion pressure. "
12/01/2005 - "To evaluate the intraocular pressure (IOP)-lowering efficacy of latanoprost in normal-tension glaucoma (NTG). "
09/01/2003 - "To study the effect of instillation of latanoprost on the diurnal variation in the intraocular pressure(IOP), blood pressure, and pulse rate in patients with normal-tension glaucoma(NTG). "
02/01/1997 - "Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: a review of short-term studies with three dose regimens of latanoprost treatment."
04/01/2015 - "To evaluate the long-term effect of latanoprost on central corneal thickness (CCT) in patients with normal-tension glaucoma (NTG). "
|2.||Timolol (Blocadren)FDA LinkGeneric
08/01/1983 - "In low-tension glaucoma it seemed the best therapy when combined with timolol. "
08/01/1982 - "Timolol maleate and intra-ocular pressure in low-tension glaucoma."
01/01/1981 - "Timolol maleate and intraocular pressure in low-tension glaucoma."
06/01/2014 - "Intraocular pressure-lowering efficacy of dorzolamide/timolol fixed combination in normal-tension glaucoma."
07/01/2008 - "Clinical efficacy of topical nipradilol and timolol on visual field performance in normal-tension glaucoma: a multicenter, randomized, double-masked comparative study."
|3.||travoprost (Travatan)FDA Link
01/01/2012 - "BAK-free travoprost monotherapy was effective in reducing intraocular pressure for at least 3 years; however, visual field performance worsened in 2.8%-13.9% of patients with normal tension glaucoma."
01/01/2014 - "This study aimed to evaluate the effect of travoprost with sofZia® preservative system for lowering the intraocular pressure (IOP) of Japanese normal tension glaucoma (NTG) patients. "
08/01/2008 - "The effect of travoprost on daytime intraocular pressure in normal tension glaucoma: a randomised controlled trial."
01/01/2014 - "The diurnal and nocturnal effects of travoprost in normal-tension glaucoma."
01/01/2014 - "Travoprost with sofZia® preservative system lowered intraocular pressure of Japanese normal tension glaucoma with minimal side effects."
|4.||Calcium Channel Blockers (Blockers, Calcium Channel)IBA
05/15/1993 - "These findings suggest that calcium channel blockers may be useful in the management of low-tension glaucoma."
04/01/2004 - "Several studies indicate that calcium channel blockers improve the clinical course of normal tension glaucoma (NTG), whereas the underlying mechanism is not fully investigated. "
01/01/1995 - "Previous studies indicated calcium channel blockers to be of some help for normal-tension glaucoma patients. "
12/01/2001 - "A long-term follow-up study demonstrated that calcium-channel blockers are efficacious in stabilizing the visual field in normal-tension glaucoma. "
01/01/1999 - "Because calcium channel blockers reduce vascular resistance, they may have a clinical application in the treatment of normal-tension glaucoma (NTG). "
|5.||bimatoprost (Lumigan)FDA Link
01/01/2014 - "Bimatoprost 0.03% single treatment was effective in reducing the IOP at least during the 3 years of treatment, but visual field performance worsened by 3.0%-12.1% in patients with normal-tension glaucoma."
09/01/2015 - "This subanalysis of the APPEAL Korea study supports use of bimatoprost 0.01 % for previously treated patients with OAG (including normal tension glaucoma) or OHT who did not reach target IOP or were intolerant of previous treatment."
01/01/2012 - "The aim of this study was to evaluate the efficacy and safety of bimatoprost ophthalmic solution 0.03% (bimatoprost) in Japanese normal-tension glaucoma (NTG) patients with an intraocular pressure (IOP) of 18 mmHg or less. "
06/01/2006 - "The aim of this study was to investigate the effects of bimatoprost 0.03% on ocular hemodynamics in patients with normal tension glaucoma (NTG). "
01/01/2014 - "Effects of treatment with bimatoprost 0.03% for 3 years in patients with normal-tension glaucoma."
01/01/2013 - "Tafluprost single-use vials treatment was effective in reducing IOP over the 3 years of this study, but visual field performance worsened by 10.3%-13.8% in patients with normal-tension glaucoma. "
05/01/2010 - "[Intraocular pressure lowering effect of 0.0015% tafluprost as compared to placebo in patients with normal tension glaucoma: randomized, double-blind, multicenter, phase III study]."
01/01/2013 - "Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma."
11/01/2011 - "To evaluate the intraocular pressure (IOP)-reducing effects and safety of 0.0015% tafluprost ophthalmic solution (tafluprost) in normal-tension glaucoma (NTG) patients with an IOP of 16 mmHg or less. "
11/01/2011 - "Efficacy and safety of tafluprost in normal-tension glaucoma with intraocular pressure of 16 mmHg or less."
|7.||Mitomycin (Mitomycin-C)FDA LinkGeneric
11/01/2014 - "To compare the outcome of deep sclerectomy (DS) with and without mitomycin-C (MMC) in patients with normal-tension glaucoma (NTG). "
11/01/2014 - "Deep sclerectomy in normal-tension glaucoma with and without mitomycin-c."
06/01/1995 - "Trabeculectomy with mitomycin C appears to have potential as a treatment modality of choice for normal-tension glaucoma, because a large majority of the patients in the present study achieved an intraocular pressure allegedly beneficial in managing normal-tension glaucoma."
03/01/2000 - "Mitomycin C trabeculectomy is effective in delaying progression of visual field defect in normal-tension glaucoma, but complications may arise and cause some visual disturbance."
05/01/2005 - "To evaluate the efficacy of and complications after trabeculectomy using mitomycin C (MMC) in Japanese normal-tension glaucoma (NTG) patients by a retrospective analysis based on the Kaplan-Meier life table method. "
08/01/2012 - "The aim of this study was to evaluate the associations between retinal vessel diameter and retinal nerve fiber layer (RNFL) thickness in patients with normal tension glaucoma (NTG). "
01/01/1999 - "This study intended to investigate the asymmetry in intraocular pressure (IOP) and that in retinal nerve fiber layer (RNFL) thickness in normal-tension glaucoma patients. "
09/01/2015 - "To quantify the degree of curvature of the retinal artery trajectory (RAT) and to investigate the relationship between the curvature and the location of a retinal nerve fiber layer defect (NFLD) in eyes with normal tension glaucoma (NTG). "
09/01/2015 - "Relationship Between Location of Retinal Nerve Fiber Layer Defect and Curvature of Retinal Artery Trajectory in Eyes With Normal Tension Glaucoma."
07/01/2015 - "Topographical correlation between macular layer thickness and clockwise circumpapillary retinal nerve fiber layer sectors in patients with normal tension glaucoma."
|9.||Fluorescein (Funduscein)FDA LinkGeneric
11/15/1993 - "We measured the diurnal aqueous humor flow in patients with low-tension glaucoma by clearance of topically applied fluorescein. "
01/01/2013 - "Fluorescein angiographic studies revealed prolonged arteriovenous passage (AVP) times and increased fluorescein filling defects in normal tension glaucoma (NTG) compared to healthy controls. "
01/01/1971 - "Fluorescein angiographic studies of the peripapillary and perilimbal regions in simple, capsular and low-tension glaucoma."
06/01/2003 - "To investigate the relation between blood flow parameters of the retrobulbar vessels measured by means of colour Doppler imaging (CDI) and fluorescein filling defects of the optic nerve head in patients with normal tension glaucoma (NTG) and control subjects. "
06/01/2003 - "Colour Doppler imaging and fluorescein filling defects of the optic disc in normal tension glaucoma."
|10.||brimonidine (Alphagan)FDA LinkGeneric
01/01/2014 - "Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma."
09/01/2004 - "To compare the effects of 2 dosing regimens of brimonidine tartrate 0.2% on diurnal intraocular pressure (IOP) and systemic hemodynamics in patients with normal-tension glaucoma (NTG). "
09/01/2004 - "Diurnal intraocular pressure and blood pressure with two dosing regimens of brimonidine in normal tension glaucoma."
08/01/2003 - "Effect of brimonidine on intraocular pressure in normal tension glaucoma: a short term clinical trial."
01/01/2003 - "A 70-year-old woman with bilateral normal tension glaucoma was treated with topical brimonidine and followed in an outpatient setting. "
09/01/2014 - "Clinical records of 34 patients with normal-tension glaucoma (12 males and 22 females) with progressive visual field loss undergoing successful trabeculectomy were studied. "
09/01/2014 - "Visual Field Progressive Rate in Normal Tension Glaucoma Before and After Trabeculectomy: A Subfield-Based Analysis."
09/01/2014 - "Visual Field Progressive Rate in Normal Tension Glaucoma Before and After Trabeculectomy."
03/01/2010 - "To determine the target intraocular pressure (IOP) level in normal-tension glaucoma (NTG) for visual field (VF) stability following trabeculectomy. "
04/01/2002 - "To evaluate the long-term effects of trabeculectomy on the progression of visual field damage in patients with progressive normal-tension glaucoma (NTG). "
02/01/2001 - "Corneal temperature as a parameter of ocular blood flow and choroidal and optic nerve blood flow as assessed by means of laser Doppler flowmetry techniques were evaluated in 12 vasospastic normal-tension glaucoma patients in a prospective, randomized, observer-masked, two-period crossover, placebo-controlled pilot trial. "
01/01/2015 - "Twenty normal tension glaucoma (NTG) patients and eighteen age- and gender-matched controls had pulsatile ocular blood flow (POBF) measurements, systemic cardiovascular assessment, and laser Doppler digital blood flow (DBF) assessed. "
11/01/2006 - "Scanning laser polarimetry with variable corneal compensation in the area of apparently normal hemifield in eyes with normal-tension glaucoma."
08/01/2004 - "Optic disc topography as measured by confocal scanning laser ophthalmoscopy and visual field loss in Japanese patients with primary open-angle or normal-tension glaucoma."
10/01/2003 - "To evaluate topographic changes in normal-tension glaucoma using serial optic disc images obtained by scanning laser tomography. "
01/01/1989 - "It is concluded that filtering surgery in low tension glaucoma may result not only in a significant lowering of IOP, but is also effective in slowing further deterioration of the visual fields."
07/01/2005 - "11 fellow eyes were under topical hypotensive therapy while 13 contralateral eyes were not (12 contralateral eyes had previous filtering surgery and one had normal tension glaucoma). "
06/01/2001 - "Should antiproliferatives be used in filtering surgery of normal tension glaucoma?"
01/01/1989 - "Filtering surgery in low tension glaucoma."
06/01/1984 - "The finding of 24-hour pressure control and a reduction in the mean peak pressure confirms the usefulness of ALT in progressive low-tension glaucoma and we recommend that it be utilized as the step in between maximally tolerated medical therapy and filtering surgery."
09/01/2014 - "The purpose of this study is to assess the effect of palmitoylethanolamide (PEA) oral administration on intraocular pressure (IOP) and visual field damage progression in normal-tension glaucoma (NTG) patients. "
03/01/2011 - "8. In a single-instituted prospective double-blinded clinical trial, oral administration of nilvadipine at 4 mg/day, a DHP calcium-channel blocker, was found to significantly retard the visual field progression in normal tension glaucoma patients over 3 years, while significantly increasing the choroidal and optic nerve blood flow by about 35%. "
11/01/2009 - "An 83-year-old woman with normal tension glaucoma was noted to have pseudophakic pseudoexfoliation of an AkreosFit IOL 5 years after uncomplicated phacoemulsification with IOL."
07/01/2007 - "To compare the midterm efficacy and safety of phacoviscocanalostomy (viscocanalostomy, phacoemulsification, and intraocular lens [IOL] implantation) and cataract surgery (phacoemulsification and IOL implantation) in patients with normal-tension glaucoma (NTG) and cataract. "
07/01/2015 - "To examine effects of phacoemulsification on longer-term intraocular pressure (IOP) in patients with medically treated primary open-angle glaucoma (POAG; including normal-tension glaucoma), pseudoexfoliation glaucoma (PXG), or primary angle-closure glaucoma (PACG), without prior or concurrent incisional glaucoma surgery. "
03/01/2006 - "Clear cornea phacoemulsification with implantation of a foldable acrylic lens was performed in 25 eyes with end-stage glaucoma (primary open-angle glaucoma including normal tension glaucoma or exfoliative glaucoma) either under topical anesthesia or under general anesthesia. "